Parvovirus B19 in Rheumatic Diseases.
Rosaria ArviaMaria A StincarelliElisabetta ManaresiGiorgio GallinellaKrystyna ZakrzewskaPublished in: Microorganisms (2024)
Parvovirus B19 (B19V) is a human pathogen belonging to the Parvoviridae family. It is widely diffused in the population and responsible for a wide range of diseases, diverse in pathogenetic mechanisms, clinical course, and severity. B19V infects and replicates in erythroid progenitor cells (EPCs) in the bone marrow leading to their apoptosis. Moreover, it can also infect, in an abortive manner, a wide set of different cell types, normally non-permissive, and modify their normal physiology. Differences in the characteristics of virus-cell interaction may translate into different pathogenetic mechanisms and clinical outcomes. Joint involvement is a typical manifestation of B19V infection in adults. Moreover, several reports suggest, that B19V could be involved in the pathogenesis of some autoimmune rheumatologic diseases such as rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), or vasculitis. This review provides basic information on the B19 virus, highlights characteristics of viral infection in permissive and non-permissive systems, and focuses on recent findings concerning the pathogenic role of B19V in rheumatologic diseases.
Keyphrases
- disease activity
- juvenile idiopathic arthritis
- systemic lupus erythematosus
- systemic sclerosis
- rheumatoid arthritis
- interstitial lung disease
- bone marrow
- single cell
- ankylosing spondylitis
- cell therapy
- endothelial cells
- oxidative stress
- multiple sclerosis
- endoplasmic reticulum stress
- candida albicans
- emergency department
- cell death
- social media
- health information
- cell proliferation
- induced pluripotent stem cells
- signaling pathway